Foxconn to Invest $30M in Robocore's Healthcare Robots

Foxconn Technology, through its subsidiary Q-Run Holdings, is set to invest up to US$30 million in Robocore’s subsidiary RoboTemi Global as part of its Series D funding round.

The deal begins with an initial US$10 million investment for a 6.6 percent stake, with two additional US$10 million tranches possible over the next two years, subject to valuation agreements. Robocore develops service robots and has deployed solutions across nearly 20,000 client sites worldwide, including over 5,000 locations in the US spanning hospitals, elderly care facilities, retail chains, and households. With fresh capital, the company plans to expand its telemedicine business in the US, Europe, and Japan, roll out new consumer products in China, and strengthen global sales and advertising operations.

Key Highlights

• Foxconn to invest up to $30M in Robocore’s RoboTemi Global
• Funds to expand telemedicine, global sales, and China consumer launches
• Move aligns with booming medical robotics market, set to hit $57B+ by 2035

For Foxconn, this marks a continuation of its long-term bet on robotics and automation. Since 2015, Foxconn has invested heavily in the sector—partnering with Alibaba to invest $120 million in SoftBank Robotics, deploying robots to replace 60,000 factory workers, and announcing ambitions for fully autonomous factories.

This latest move represents a strategic shift from manufacturing automation to service and healthcare robotics, leveraging Foxconn’s supply chain scale and production expertise.

Also Read: Foxconn Launches First Chinese LLM to Advance AI in Manufacturing

The timing aligns with booming market forecasts: the global medical robotics market is expected to rise from $18.29 billion in 2024 to $57.31 billion by 2035 (CAGR 10.94 percent), while surgical robotics alone could jump from $11.10 billion to $51.12 billion by 2034 (CAGR 16.5 percent). With aging populations and rising demand for telemedicine, Foxconn’s entry via Robocore positions it strongly in one of the fastest-growing healthcare technology markets.